Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eve vs Nurx

Eve
Graded #210

Lower grade

vs+0.20000000000000284
Nurx
Graded #200

Higher grade

The verdict

Nurx takes it — 66.2/100 to 66/100, but only just.

Nurx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Established women's telehealth brand offering tiered GLP-1 weight loss programs. Eve is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNurx +6
54
60
Dose & formulationEve +11
88
77
Clinical oversightEven
79
79
Labs & monitoringEven
52
52
FulfillmentEve +2
67
65
Contract termsNurx +14
41
55
Eve · left barNurx · right bar

The numbers

MetricEveNurx
WeighScore66/10066.2/100
GradeCC
Scorecard rank#210#200
Semaglutide$195/mo (compounded)$179/mo (starting dose, compounded)
Tirzepatide$195/mo (compounded)$179/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesInjection only
Eve

Graded #210 · C

Strengths

  • Genuinely women's-health-focused — fills a real gap among gender-neutral GLP-1 competitors
  • Both compounded and brand-name FDA-approved options (Wegovy/Ozempic/Mounjaro) on one platform — rare
  • LegitScript Certified with a verifiable ID
  • Publishes the FDA compounded-medication disclaimer
  • Oral sublingual semaglutide offered alongside injectable

Where it loses points

  • Full states-served list not disclosed publicly
  • 503A pharmacy partner not named, and 503A vs 503B status not specified
  • Named medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed
  • Governing law / arbitration venue not stated
Nurx

Graded #200 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard